The Menarini Stemline team in France is proud to participate in the first Cours St-Paul in Hematology this week! This inaugural event marks a milestone in advancing knowledge and collaboration in hematology. Menarini Stemline is committed to addressing unmet needs and delivering innovative solutions for patients with rare and complex hematological conditions. If you are onsite, be sure to visit our booth! #Hematology #InnovationInHealthcare #Collaboration #MenariniStemlineFrance
Menarini Stemline’s Post
More Relevant Posts
-
We are pleased to share that Dr. Aastha Gupta will be moderating the session on “WHO vs ICC classification for Myeloid Neoplasms - Insights and Pitfalls” in the webinar series on Innovations in Hematology. Registration Link: https://lnkd.in/ge74XReY #AgilusDiagnostics #hematology
-
-
Hospital Management student , continuously learning and ready to for revolutionize healthcare operations.
Attend the Webinar: WHO vs ICC Classification for Myeloid Neoplasms with Dr. Aastha Gupta! Join the webinar series on Innovations in Hematology and gain insights into Myeloid Neoplasm classifications. Dr. Aastha Gupta will moderate the session, discussing the WHO and ICC classifications, their strengths, and potential challenges. Don't miss this valuable learning opportunity! [Register Now]
We are pleased to share that Dr. Aastha Gupta will be moderating the session on “WHO vs ICC classification for Myeloid Neoplasms - Insights and Pitfalls” in the webinar series on Innovations in Hematology. Registration Link: https://lnkd.in/ge74XReY #AgilusDiagnostics #hematology
-
-
Exciting news for hematology researchers! Soon launching: TrailBio™ Hematopoietic Progenitor Cells (HPCs). Derived from iPSCs, these cells are capable of multilineage differentiation. Want to be the first to know when TrailBio™ HPCs hit the market? Visit https://lnkd.in/gb6f6Sd8 to sign up for our newsletter and receive the latest updates. #HematopoieticCells #StemCells #Hematology #DrugDiscovery #RegenerativeMedicine #iPSCs
-
-
Today we announced details from a poster presentation shared at the 2024 American Society of Hematology (ASH) Annual Meeting with final data from the Phase 2 REVIVE study for polycythemia vera (PV). See more details in our latest press release: https://bit.ly/49C95rm #ASH24 | #hematology | #bloodcancer
-
#News for #Investors and #Media: We are a month away from the biggest hematology event of the year, #ASH24. Learn more about how we are progressing our #hematology innovation and addressing the needs of patients facing B-cell malignancies: https://bit.ly/3YVOcT9
-
-
Explore the front-runners shaping the future of hematology. https://lnkd.in/gZqfMgj9 #MedicoReach #Hematology #MedicalInnovation #HematologyAdvances #HematologyInnovators #HematologyProgress #HealthInnovation
-
-
Honored to have participated in the insightful webinar on Blood Transfusion - Indications, Screening Criteria, and Complications, organized by the LMDC Blood Donation Society on 14th September, 2024. Grateful for the opportunity to deepen my understanding of this critical aspect of hematology with renowned experts in the field. Looking forward to applying this knowledge in future practice! #BloodTransfusion #Hematology #LMDC #MedicalEducation #LifelongLearning"
-
-
"Thrilled to announce that I've clinched first prize at the Uttar Pradesh Hematology Group Conference, hosted by KGMU's Department of Clinical Hematology! My oral presentation on 'Von Willebrand disease' garnered recognition and applause from esteemed peers in the field. Grateful for the opportunity to share insights and contribute to advancing knowledge in hematology. Looking forward to more fruitful collaborations and discoveries ahead! #Hematology #VonWillebrandDisease #ResearchExcellence"
-
-
Agilus Diagnostics is participating in UP HGCON 2024, 1st Annual Conference of Uttar Pradesh Hematology Group to be held on 27th & 28th April, 2024 in Lucknow. The theme of the conference is Exploring Emerging Concepts in Hematology. #AgilusDiagnostics #hematology
-
